Alligator Makes Advances In Pancreatic Cancer
Mitazalimab Succeeds In Interim Phase II Readout
The Swedish biotech is expecting intense discussions with prospective partners for mitazalimab, a couple of years after Janssen returned the rights to the CD40 agonist.
